Latest Gynecologic oncology Stories

WYNNEWOOD, Pa., Sept. 2, 2011 /PRNewswire/ -- As a leading cause of death among women, ovarian cancer is known as a "silent killer." Rarely detected early, when it is more easily treated, ovarian cancer strikes over 20,000 women each year. It is estimated that over 15,000 women in America die each year from the disease. In the Philadelphia area, the Lorraine J. D'Emilio Foundation was started in 2011 in memory and honor of Lorraine J. D'Emilio. The foundation focuses on helping and...

OSCEOLA, Ind., Aug. 30, 2011 /PRNewswire/ -- Tatum Ink - Freelance journalist Rita Tatum wants to lowercase the "Big C" in advanced uterine cancer diagnoses. "Surviving cancer's okay, but living's more fun," insists the author of Sass cancer Back: Living with Spirit (Xlibris: 2011). In 2006, Tatum was diagnosed with stage IV uterine cancer. "Early on, I survived like a deer frozen in oncoming headlights," Tatum says. "But faith, friends' prayers and timely doses of humor soon had me...

OSCEOLA, Ind., Aug. 15, 2011 /PRNewswire/ -- Tatum Ink -- One of every 41 U.S. women will be diagnosed with uterine cancer in her lifetime. More than half will be 50 to 69 years old. In 2006, freelance journalist Rita Tatum, author of Sass cancer Back: Living with Spirit (Xlibris: 2011), became one of them. Uterine cancer, also called endometrial cancer, starts in the uterus' inner lining. When caught in early stages, it's highly curable. Five-year survival drops to between 15 and 25...

MIAMI, June 16, 2011 /PRNewswire/ -- Drs. Nicholas C. Lambrou and Troy A. Gatcliffe are pleased to announce the opening of GYN Oncology of Miami. Fellowship trained in gynecologic oncology, Drs. Lambrou and Gatcliffe are specialists in the surgical and medical care of women's reproductive cancers. The new practice provides comprehensive gynecology services to women in South Florida and the Caribbean region from two convenient office locations in the Medical Arts Buildings of South Miami and...

PITTSBURGH, June 6, 2011 /PRNewswire/ -- Dr. Bradley Monk of the Creighton University School of Medicine presented a new gynecologic cancer study at the 2011 American Society of Clinical Oncology (ASCO) Annual Symposium, June 5th in Chicago, Illinois. The study, titled, Acquired Drug Resistance in Gynecologic Cancer Detected by an In Vitro Assay, begins to answer the question of whether ChemoFx® Drug Response Marker test results taken in the primary setting can be utilized for...

MALVERN, Pa., June 6, 2011 /PRNewswire/ -- A study recently published online in the journal Clinica Chimica Acta validated the use of the HE4 test and the ROMA (Risk of Ovarian Malignancy Algorithm) algorithm in distinguishing malignant from benign pelvic masses in the Italian population. The authors of this study concluded that HE4 should be added to clinical and imaging criteria for the discrimination of benign from malignant pelvic masses in women suspected of having epithelial ovarian...

Recommendations published in the American Journal of Obstetrics and GynecologyAlthough gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors. Because long-term survival is now more common, it is increasingly important to detect recurrence. The Clinical Practice Committee of the Society of Gynecologic Oncology (SGO) has released a Clinical Document outlining their expert recommendations for cancer...

MADISON, N.J. and AUSTIN, Texas, May 24, 2011 /PRNewswire/ -- A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative assessment alone. The study is the second published online this month in the journal, which is the official publication of the American College of Obstetricians and Gynecologists (ACOG), to show OVA1's...

WORD OF HOPEâ„¢ Now Available Through New Website, iTunes, YouTube, and Other Online Sources Indianapolis, Indiana (PRWEB) May 14, 2011 A new ovarian cancer educational podcast series, entitled "WORD of HOPEâ„¢," was launched during Women's Health Awareness Week through a collaborative initiative of Libby's Hope (LH) and Women's Oncology Research & Dialogue (WORD). The WORD of HOPEâ„¢ Ovarian Cancer podcast series will address important topics related to ovarian cancer,...

MADISON, N.J. and AUSTIN, Texas, May 12, 2011 /PRNewswire/ -- A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test. The study builds on prior...